Neu-164, a novel antioxidant and anti-inflammatory compound reduces lung inflammation in a murine model of allergic asthma

C. Dick, R. Clayton, M. Laudon, E. Pinner (Glasgow, United Kingdom; Tel Aviv, Israel)

Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Session: Comorbid cardiovascular condition and therapy of asthma
Session type: Thematic Poster Session
Number: 501
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Dick, R. Clayton, M. Laudon, E. Pinner (Glasgow, United Kingdom; Tel Aviv, Israel). Neu-164, a novel antioxidant and anti-inflammatory compound reduces lung inflammation in a murine model of allergic asthma. Eur Respir J 2008; 32: Suppl. 52, 501

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Neu-164, a novel antioxidant and anti-inflammatory compound, reduces cigarette smoke-induced lung inflammation
Source: Annual Congress 2008 - COPD
Year: 2008


Ovalbumin-induced asthma model in Brown Norway rats demonstrates potential anti-asthmatic effects of Neu-164, a novel antioxidant and anti-inflammatory compound
Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models
Year: 2008

Narirutin inhibits airway inflammation in an allergic mouse model
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010

Neutraligands of CXCL12: Anti-inflammatory activity in an allergic model of asthma
Source: Annual Congress 2011 - Models of disease and drug actions
Year: 2011


Effect of SMP-028, a novel anti-inflammatory agent, on experimental allergic asthma in guinea pig model
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010

Antioxidant, γ-glutamylcysteinylethyl ester, ameliorates airway hyperresponsiveness in a mouse asthma model
Source: Eur Respir J 2006; 28: Suppl. 50, 224s
Year: 2006

Anti-inflammatory and anti-asthmatic effects of resolvin E1 in a mouse model of allergic asthma
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009


The therapeutic efficacy of OAT-889 (dual AMCase/CHIT1 inhibitor) in comparison to montelukast in HDM-induced model of chronic airway inflammation in mice
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017

Pharmacological characterization of the protective effect of mepolizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019

A role of fungal extracts on allergic airway inflammation in the ovalbumin-induced asthma model
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010

Adjuvant and anti-inflammatory properties of cigarette smoke in murine models of allergic airways inflammation
Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models
Year: 2008

The anti-inflammatory effects of helminth-derived peptides in a model of endotoxin-induced acute lung injury
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021


An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in the mouse
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013

ST2 gene knockout attenuates allergic airways disease
Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs
Year: 2006


MMP-9 deficiency reduces airway inflammation and hyperresponsiveness in a mouse model of asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 20s
Year: 2001

Pharmacological characterization of the protective effect of benralizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019

Effect of a novel inhaled glucocorticoid, ciclesonide, on an allergen-induced asthmatic response in rats and its prolonged anti-inflammatory activity in vitro
Source: Eur Respir J 2002; 20: Suppl. 38, 91s
Year: 2002

Dose-dependent effects of muIL-13Rα2, a potent IL-13 neutraliser, on the phenotype of an acute allergic airways inflammation model in BALB/c mice
Source: Annual Congress 2004 - Animal models of asthma and chronic bronchitis and their relevance in pulmonary pharmacology
Year: 2004


HIF-1α inhibitor, 2ME2, attenuates airway inflammation and hyperresponsiveness in allergic airway disease
Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Year: 2008


Effects of IL-4Rα blockade on lung inflammation and airway hyperresponsiveness using Mu317RAXMu, a murine surrogate for AMG 317, in a treatment model of cockroach allergen-induced asthma in mice
Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation
Year: 2008